三种Schistosomamansoni菌株的比较:感染,形状和对治疗的敏感性
Marilia Bergamini Valentini1, Tiago Manuel Fernandes Mendes1, Silmara Marques Allegretti1
1Department of Animal Biology, Institute of Biology, University of Campinas, Campinas, São Paulo, Brazil.
Experimental parasitology
|August 11, 2025
概括
不同的Schistosoma mansoni菌株对杆菌病有不同的影响. 一个菌株 (SmSE) 表现出对实验量子治疗的耐药性,突出了了解菌株变异性的必要性,以进行有效的控制.
科学领域:
- 寄生虫学的寄生虫学
- 传染性疾病 传染性疾病
- 药物耐药性 药物耐药性 药物耐药性
背景情况:
- 斯基斯托索马曼索尼菌株表现出不同的表型,影响疾病控制.
- 了解菌株特异性特征对于杆菌病的管理至关重要.
研究的目的:
- 为了比较巴西的Schistosoma mansoni菌株 (SmBH,SmSE,SmSJ) 在感染,形态和PZQ反应方面.
- 在小鼠模型中评估不同S. mansoni菌株的致病性和药物易感性.
主要方法:
- BALB/c小鼠感染了巴西的三种S. mansoni菌株 (SmBH,SmSE,SmSJ).
- 感染后45天使用不同剂量的PZQ治疗.
- 监测卵子的排泄,虫负担,颗粒瘤的形成和形态分析.
主要成果:
- SmBH菌株的感染率和卵产量更高;SmSE雌性更长;SmBH卵更大.
- SmSE诱导较小的颗粒瘤,而SmBH感染导致更多的颗粒瘤,表明更高的致病性.
- PZQ有效地减少了SmBH和SmSJ的寄生虫负担和病理,但SmSE对PZQ治疗表现出显著的耐药性.
结论:
- 在S. mansoni菌株中存在表型变异,影响疾病严重程度和治疗结果.
- SmBH菌株通过更高的卵产加剧了病理,SmSJ的卵产量最低,SmSE表现出PZQ耐药性.
- 了解S. mansoni菌株的变异性对于开发改进的杆菌病控制策略和新的药物疗法至关重要.
相关概念视频
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...